Ximena Lopez, M.D.
Associate Professor

Dr. Lopez did her residency in Pediatrics at the University of Illinois at Chicago, IL,  and her fellowship in Pediatric Endocrinology at Massachusetts General Hospital/Harvard Medical School,  Boston, MA.

She has performed research in the area of type 2 diabetes and obesity in adults and pediatrics  and has participated in several multicenter clinical trials with new drugs for type 2 diabetes.

She is currently the Medical Director for the GENder, Education and Care Interdisciplinary Support (GENECIS) program, which provides mental health and endocrine care for gender non-conforming children and adolescents. Dr. Lopez is also currently co-chair of the Transgender Health Special Interest Group of the Pediatric Endocrine Society.

Medical School

Universidad La Salle/Facuitad de Medicina (2000)

Residency

University of Illinois at Chicago (2005), Pediatrics

Fellowship

Massachusetts General Hospital (2008), Pediatric Endocrinology

• Gender dysphoria in children and adolescents
• Metabolic effects of endocrine therapy in adolescents with gender dysphoria
• Neurobiology of transgender children and adolescents

Featured Publications

Statement on gender-affirmative approach to care from the pediatric endocrine society special interest group on transgender health.

Lopez X, Marinkovic M, Eimicke T, Rosenthal SM, Olshan JS Curr. Opin. Pediatr. 2017 May

Approach to Children and Adolescents with Gender Dysphoria.

Lopez X, Stewart S, Jacobson-Dickman E Pediatr Rev 2016 Mar 37 3 89-98

A role of the Inflammasome in the low storage capacity of the abdominal subcutaneous adipose tissue in obese adolescents.

Kursawe R, Dixit VD, Scherer PE, Santoro N, Narayan D, Gordillo R, Giannini C, Lopez X, Pierpont B, Nouws J, Shulman GI, Caprio S Diabetes 2015 Dec

Association of Non-High-Density Lipoprotein Cholesterol with Psychosocial Dysfunction in Children and Adolescents with Obesity.

Serrano-Gonzalez M, McConnel C, Bokhary M, Oden J, Lopez X Child Obes 2015 Sep

Effect of pioglitazone on plasma ceramides in adults with metabolic syndrome.

Warshauer JT, Lopez X, Gordillo R, Hicks J, Holland WL, Anuwe E, Blankfard MB, Scherer PE, Lingvay I Diabetes Metab. Res. Rev. 2015 May

Liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial.

Klein DJ, Battelino T, Chatterjee DJ, Jacobsen LV, Hale PM, Arslanian S Diabetes Technol. Ther. 2014 Oct 16 10 679-87

Cromolyn sodium for insulin-induced lipoatrophy: old drug, new use.

Phua EJ, Lopez X, Ramus J, Goldfine AB Diabetes Care 2013 Dec 36 12 e204-5

Plasma ceramides are elevated in female children and adolescents with type 2 diabetes.

Lopez X, Goldfine AB, Holland WL, Gordillo R, Scherer PE J. Pediatr. Endocrinol. Metab. 2013 Apr 1-4

An infant with hypercalcemia and rachitic changes: question.

Siddique K, Lucke A, Lucio D, Lopez X, Seikaly M Pediatr. Nephrol. 2013 Feb 28 2 245-6, 247-9

Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans.

Halperin F, Lopez X, Manning R, Kahn CR, Kulkarni RN, Goldfine AB Diabetes 2012 Feb 61 2 301-9

 Featured Books

Hypoglycemia in Infants and Children. In Pediatric Nutrition, 7th Edition, R. Kleinman, F. Greer, eds.

McManus S, Lopez X, Levitsky L. (2013). American Academy of Pediatrics

• Best grades of graduating class from Medical School
  Universidad La Salle Medical School, Mexico City (2000)
• Graduation from Medical School with Honors
  Universidad La Salle Medical School, Mexico City (2000)

• American Academy of Pediatrics, Endocrinology Executive Committee Member (2016-2019)
• Pediatric Endocrine Society, Co-chair of the Transgender and Gender Non-Conforming Youth SIG (2015)
• World Professional Association for Transgender Health (WPATH) (2014)
• Diabetes National Medical Advisor, Novo Nordisk, Spain (2008-2010)